Lecap Asset Management Ltd. boosted its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 89.4% during the 4th quarter, Holdings Channel reports. The firm owned 34,198 shares of the business services provider’s stock after buying an additional 16,139 shares during the period. Lecap Asset Management Ltd.’s holdings in Genpact were worth $1,469,000 at the end of the most recent reporting period.
A number of other large investors also recently added to or reduced their stakes in the business. Franklin Resources Inc. increased its holdings in shares of Genpact by 6.5% in the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock worth $162,318,000 after purchasing an additional 252,674 shares during the last quarter. Geode Capital Management LLC grew its holdings in Genpact by 12.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock valued at $148,142,000 after buying an additional 413,646 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Genpact by 192.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after acquiring an additional 2,060,595 shares during the last quarter. ARGA Investment Management LP raised its holdings in shares of Genpact by 14.1% during the 4th quarter. ARGA Investment Management LP now owns 772,917 shares of the business services provider’s stock worth $33,197,000 after acquiring an additional 95,413 shares in the last quarter. Finally, Los Angeles Capital Management LLC bought a new position in shares of Genpact during the 3rd quarter valued at approximately $19,779,000. 96.03% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
G has been the topic of several research reports. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price target for the stock from $45.00 to $60.00 in a research report on Friday. Robert W. Baird boosted their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Needham & Company LLC lifted their price target on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $47.63.
Insider Transactions at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the transaction, the chief executive officer now owns 267,404 shares in the company, valued at approximately $11,926,218.40. The trade was a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 35,058 shares of company stock valued at $1,558,675. 2.80% of the stock is currently owned by company insiders.
Genpact Price Performance
Shares of G stock opened at $54.98 on Friday. The stock has a 50 day moving average price of $44.92 and a 200 day moving average price of $41.15. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85. The firm has a market capitalization of $9.70 billion, a P/E ratio of 15.10, a P/E/G ratio of 1.61 and a beta of 1.20.
Genpact (NYSE:G – Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 21.85% and a net margin of 14.22%. As a group, sell-side analysts predict that Genpact Limited will post 2.94 earnings per share for the current year.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This is an increase from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date is Tuesday, March 11th. Genpact’s dividend payout ratio is currently 16.76%.
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.